Literature DB >> 17181544

Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.

Juan J Sanchez1, Gemma Monaghan, Claus Børsting, Gail Norbury, Niels Morling, H Bobby Gaspar.   

Abstract

Inherited adenosine deaminase (ADA) deficiency is a rare metabolic disorder that causes immunodeficiency, varying from severe combined immunodeficiency (SCID) in the majority of cases to a less severe form in a small minority of patients. Five patients of Somali origin from four unrelated families, with severe ADA-SCID, were registered in the Greater London area. Patients and their parents were investigated for the nonsense mutation Q3X (ADA c7C>T), two missense mutations K80R (ADA c239A>G) and R142Q (ADA c425G>A), and a TAAA repeat located at the 3' end of an Alu element (AluVpA) positioned 1.1 kb upstream of the ADA transcription start site. All patients were homozygous for the haplotype ADA-7T/ADA-239G/ADA-425G/AluVpA7. Among 207 Somali immigrants to Denmark, the frequency of ADA c7C>T and the maximum likelihood estimate of the frequency of the haplotype ADA-7T/ADA-239G/ADA-425G/AluVpA7 were both 0.012 (carrier frequency 2.4%). Based on the analysis of AluVpA alleles, the ADA c7C/T mutation was estimated to be approximately 7,100 years old. Approximately 1 out of 5 - 10000 Somali children will be born with ADA deficiency due to an ADA c7C/T mutation, although within certain clans the frequency may be significantly higher. ADA-SCID may be a frequent immunodeficiency disorder in Somalia, but will be underdiagnosed due to the prevailing socioeconomic and nutritional deprivation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181544     DOI: 10.1111/j.1469-1809.2006.00338.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  14 in total

1.  Forensic and phylogeographic characterisation of mtDNA lineages from Somalia.

Authors:  Martin Mikkelsen; Liane Fendt; Alexander W Röck; Bettina Zimmermann; Eszter Rockenbauer; Anders J Hansen; Walther Parson; Niels Morling
Journal:  Int J Legal Med       Date:  2012-04-14       Impact factor: 2.686

Review 2.  History and current status of newborn screening for severe combined immunodeficiency.

Authors:  Antonia Kwan; Jennifer M Puck
Journal:  Semin Perinatol       Date:  2015-04-30       Impact factor: 3.300

3.  Comparison of elapegademase and pegademase in ADA-deficient patients and mice.

Authors:  L Murguia-Favela; W Min; R Loves; M Leon-Ponte; E Grunebaum
Journal:  Clin Exp Immunol       Date:  2020-02-09       Impact factor: 4.330

4.  Primary immunodeficiency diseases worldwide: more common than generally thought.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Ibtihal Benhsaien; Nizar Mahlaoui; Jean-Laurent Casanova; Laurent Abel
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

Review 5.  Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.

Authors:  Gabriel S Chiu; Gregory G Freund
Journal:  Metabolism       Date:  2014-09-26       Impact factor: 8.694

6.  A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants.

Authors:  J Yancoski; C Rocco; A Bernasconi; M Oleastro; L Bezrodnik; C Vrátnica; F Haerynck; S D Rosenzweig
Journal:  Infect Genet Evol       Date:  2009-03-09       Impact factor: 3.342

7.  Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.

Authors:  Avni Y Joshi; Erin K Ham; Neel B Shah; Xiangyang Dong; Shakila P Khan; Roshini S Abraham
Journal:  Case Reports Immunol       Date:  2012-05-31

Review 8.  Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials.

Authors:  Jixin Zhong; Quan Gong; Aditya Goud; Srividya Srinivasamaharaj; Sanjay Rajagopalan
Journal:  J Diabetes Res       Date:  2015-05-14       Impact factor: 4.011

9.  A Label-Free Fluorescent Assay for the Rapid and Sensitive Detection of Adenosine Deaminase Activity and Inhibition.

Authors:  Xinxing Tang; Kefeng Wu; Han Zhao; Mingjian Chen; Changbei Ma
Journal:  Sensors (Basel)       Date:  2018-07-27       Impact factor: 3.576

10.  IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY.

Authors:  Cristina Meehan; Carmem Bonfim; Joseph F Dasso; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Jolan Walter
Journal:  Rev Paul Pediatr       Date:  2018 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.